{"id":3268,"date":"2019-01-18T14:53:18","date_gmt":"2019-01-18T14:53:18","guid":{"rendered":"https:\/\/lynxee.consulting\/?p=3268"},"modified":"2023-01-26T09:45:00","modified_gmt":"2023-01-26T09:45:00","slug":"france-new-national-strategy-on-endocrine-disruptors-2","status":"publish","type":"post","link":"https:\/\/lynxee.consulting\/en\/france-new-national-strategy-on-endocrine-disruptors-2\/","title":{"rendered":"FRANCE: New National Strategy on Endocrine disruptors"},"content":{"rendered":"\r\n

The second draft national strategy on endocrine disruptors (SNPE 2) was published in mid-January by the Ministries of Health and Ecological Transition. This new action plan will update the first national strategy, initiated in 2014. A public consultation was initiated on 14 January and will run until 8 February.<\/p>\r\n\r\n\r\n\r\n

Three main objectives have been presented as part of this new national strategy:<\/p>\r\n\r\n\r\n\r\n

Protect the population, train and inform<\/strong><\/h4>\r\n\r\n\r\n\r\n

As part of this 1st objective, ANSES will be responsible for establishing a unique and scientifically robust list of endocrine disrupting substances<\/strong> (ED) by the end of 2021. This list will be based in particular on data from the scientific literature as well as on different already existing lists. The idea is to produce a continuously updated list shared with other Member States.<\/p>\r\n\r\n\r\n\r\n

The government also wants to promote at the European level a common definition of ED<\/strong> in all chemical regulations \u2012 which would consider 3 levels of evidence: proven, presumed and suspected.<\/p>\r\n\r\n\r\n\r\n

Other actions will also be undertaken to facilitate access to information on the risks associated with the use of certain chemicals by the general public (e.g.<\/em> informative website, communication campaign).<\/p>\r\n\r\n\r\n\r\n

Prevent environmental contamination<\/strong><\/h4>\r\n\r\n\r\n\r\n

As part of this 2nd objective, a platform will be created on the data.gouv.fr<\/a> portal by 2020 in order to collect and centralise all the data concerning the occurrence of PE in the environmental compartments<\/strong>. The government also plans to strengthen the collection of data by conducting monitoring campaigns in soil and air, and by continuing and further developing the monitoring in aquatic compartments that are already in place in the context of the Water Framework Directive.<\/p>\r\n\r\n\r\n\r\n

The French Agency for Biodiversity will be mandated to carry out a review of the effects of ED on the environment<\/strong>, as well as to discuss a possible modification of the regulatory acceptable limits<\/strong> of PE in environmental compartments, in consultation with the French National Institute for Industrial Environment and Risks.<\/p>\r\n\r\n\r\n\r\n

In addition, ED will be included in the next Total Diet Study<\/strong> conducted by ANSES in order to monitor exposure of the population to chemicals present in foods.<\/p>\r\n\r\n\r\n\r\n

Improve knowledge on endocrine disruptors<\/strong><\/h4>\r\n\r\n\r\n\r\n

Under this 3rd objective, the executive plans to strengthen scientific research<\/strong> around the impact of ED on human health and the environment. A reflection will also be conducted to broaden the monitoring of ED to other health indicators<\/strong>, taking into account the diversity of disorders and pathologies reported in the literature.<\/p>\r\n\r\n\r\n\r\n

Finally, the French government will promote the substitution of ED<\/strong> to industry stakeholders through working groups and projects involving various actors from industry, consumer associations, etc<\/em>.<\/p>\r\n\r\n\r\n\r\n

To download (in French): <\/strong><\/p>\r\n\r\n\r\n\r\n

Draft of strategic goal<\/a>s<\/a><\/p>\r\n\r\n\r\n\r\n

Draft action plan<\/a><\/p>\r\n\r\n\r\n\r\n

Draft of the 13 main measures<\/a><\/p>\r\n\r\n\r\n\r\n\r\n\r\n

 <\/p>\r\n

Lynxee consulting<\/b>\u2019s team is at your disposal to answer your questions.<\/p>\r\n

Contact us!<\/b> https:\/\/lynxee.consulting\/en\/contact\/<\/a><\/p>\r\n

 <\/p>\r\n

 <\/p>\r\n

Photo credit: Myriams-Fotos\/pixabay<\/h6>\r\n

 <\/p>\r\n","protected":false},"excerpt":{"rendered":"

The second draft national strategy on endocrine disruptors (SNPE 2) was published in mid-January by the Ministries of Health and Ecological Transition. This new action plan [\u2026]<\/span><\/p>\n","protected":false},"author":7,"featured_media":3246,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[33],"tags":[118,68,124,181],"class_list":["post-3268","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-endocrine-disruptors","tag-france-en","tag-france-en-2","tag-perturbateurs-endocriniens-en"],"yoast_head":"\nFRANCE: New National Strategy on Endocrine disruptors - Lynxee consulting<\/title>\n<meta name=\"description\" content=\"The second draft national strategy on endocrine disruptors (SNPE 2) was published in mid-January by the Ministries of Health and Ecological Transition.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/lynxee.consulting\/en\/france-new-national-strategy-on-endocrine-disruptors-2\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"FRANCE: New National Strategy on Endocrine disruptors - Lynxee consulting\" \/>\n<meta property=\"og:description\" content=\"The second draft national strategy on endocrine disruptors (SNPE 2) was published in mid-January by the Ministries of Health and Ecological Transition.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/lynxee.consulting\/en\/france-new-national-strategy-on-endocrine-disruptors-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Lynxee consulting\" \/>\n<meta property=\"article:published_time\" content=\"2019-01-18T14:53:18+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-01-26T09:45:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/lynxee.consulting\/wp-content\/uploads\/2019\/02\/beaded-1421178_1920.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1287\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Adrien Margerit\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Adrien Margerit\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/lynxee.consulting\/en\/france-new-national-strategy-on-endocrine-disruptors-2\/\",\"url\":\"https:\/\/lynxee.consulting\/en\/france-new-national-strategy-on-endocrine-disruptors-2\/\",\"name\":\"FRANCE: New National Strategy on Endocrine disruptors - Lynxee consulting\",\"isPartOf\":{\"@id\":\"https:\/\/lynxee.consulting\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/lynxee.consulting\/en\/france-new-national-strategy-on-endocrine-disruptors-2\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/lynxee.consulting\/en\/france-new-national-strategy-on-endocrine-disruptors-2\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/lynxee.consulting\/wp-content\/uploads\/2019\/02\/beaded-1421178_1920.jpg\",\"datePublished\":\"2019-01-18T14:53:18+00:00\",\"dateModified\":\"2023-01-26T09:45:00+00:00\",\"author\":{\"@id\":\"https:\/\/lynxee.consulting\/#\/schema\/person\/8bd656ad92ca721913ddf5433730d240\"},\"description\":\"The second draft national strategy on endocrine disruptors (SNPE 2) was published in mid-January by the Ministries of Health and Ecological Transition.\",\"breadcrumb\":{\"@id\":\"https:\/\/lynxee.consulting\/en\/france-new-national-strategy-on-endocrine-disruptors-2\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/lynxee.consulting\/en\/france-new-national-strategy-on-endocrine-disruptors-2\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/lynxee.consulting\/en\/france-new-national-strategy-on-endocrine-disruptors-2\/#primaryimage\",\"url\":\"https:\/\/lynxee.consulting\/wp-content\/uploads\/2019\/02\/beaded-1421178_1920.jpg\",\"contentUrl\":\"https:\/\/lynxee.consulting\/wp-content\/uploads\/2019\/02\/beaded-1421178_1920.jpg\",\"width\":1920,\"height\":1287},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/lynxee.consulting\/en\/france-new-national-strategy-on-endocrine-disruptors-2\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/lynxee.consulting\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"FRANCE: New National Strategy on Endocrine disruptors\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/lynxee.consulting\/#website\",\"url\":\"https:\/\/lynxee.consulting\/\",\"name\":\"Lynxee consulting\",\"description\":\"Innovative support for regulatory issues\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/lynxee.consulting\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/lynxee.consulting\/#\/schema\/person\/8bd656ad92ca721913ddf5433730d240\",\"name\":\"Adrien Margerit\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/lynxee.consulting\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/lynxee.consulting\/wp-content\/uploads\/2023\/10\/AMA_WP-96x96.jpg\",\"contentUrl\":\"https:\/\/lynxee.consulting\/wp-content\/uploads\/2023\/10\/AMA_WP-96x96.jpg\",\"caption\":\"Adrien Margerit\"},\"url\":\"https:\/\/lynxee.consulting\/en\/author\/adrien-margerit\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"FRANCE: New National Strategy on Endocrine disruptors - Lynxee consulting","description":"The second draft national strategy on endocrine disruptors (SNPE 2) was published in mid-January by the Ministries of Health and Ecological Transition.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/lynxee.consulting\/en\/france-new-national-strategy-on-endocrine-disruptors-2\/","og_locale":"en_US","og_type":"article","og_title":"FRANCE: New National Strategy on Endocrine disruptors - Lynxee consulting","og_description":"The second draft national strategy on endocrine disruptors (SNPE 2) was published in mid-January by the Ministries of Health and Ecological Transition.","og_url":"https:\/\/lynxee.consulting\/en\/france-new-national-strategy-on-endocrine-disruptors-2\/","og_site_name":"Lynxee consulting","article_published_time":"2019-01-18T14:53:18+00:00","article_modified_time":"2023-01-26T09:45:00+00:00","og_image":[{"width":1920,"height":1287,"url":"https:\/\/lynxee.consulting\/wp-content\/uploads\/2019\/02\/beaded-1421178_1920.jpg","type":"image\/jpeg"}],"author":"Adrien Margerit","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Adrien Margerit","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/lynxee.consulting\/en\/france-new-national-strategy-on-endocrine-disruptors-2\/","url":"https:\/\/lynxee.consulting\/en\/france-new-national-strategy-on-endocrine-disruptors-2\/","name":"FRANCE: New National Strategy on Endocrine disruptors - Lynxee consulting","isPartOf":{"@id":"https:\/\/lynxee.consulting\/#website"},"primaryImageOfPage":{"@id":"https:\/\/lynxee.consulting\/en\/france-new-national-strategy-on-endocrine-disruptors-2\/#primaryimage"},"image":{"@id":"https:\/\/lynxee.consulting\/en\/france-new-national-strategy-on-endocrine-disruptors-2\/#primaryimage"},"thumbnailUrl":"https:\/\/lynxee.consulting\/wp-content\/uploads\/2019\/02\/beaded-1421178_1920.jpg","datePublished":"2019-01-18T14:53:18+00:00","dateModified":"2023-01-26T09:45:00+00:00","author":{"@id":"https:\/\/lynxee.consulting\/#\/schema\/person\/8bd656ad92ca721913ddf5433730d240"},"description":"The second draft national strategy on endocrine disruptors (SNPE 2) was published in mid-January by the Ministries of Health and Ecological Transition.","breadcrumb":{"@id":"https:\/\/lynxee.consulting\/en\/france-new-national-strategy-on-endocrine-disruptors-2\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/lynxee.consulting\/en\/france-new-national-strategy-on-endocrine-disruptors-2\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/lynxee.consulting\/en\/france-new-national-strategy-on-endocrine-disruptors-2\/#primaryimage","url":"https:\/\/lynxee.consulting\/wp-content\/uploads\/2019\/02\/beaded-1421178_1920.jpg","contentUrl":"https:\/\/lynxee.consulting\/wp-content\/uploads\/2019\/02\/beaded-1421178_1920.jpg","width":1920,"height":1287},{"@type":"BreadcrumbList","@id":"https:\/\/lynxee.consulting\/en\/france-new-national-strategy-on-endocrine-disruptors-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/lynxee.consulting\/en\/"},{"@type":"ListItem","position":2,"name":"FRANCE: New National Strategy on Endocrine disruptors"}]},{"@type":"WebSite","@id":"https:\/\/lynxee.consulting\/#website","url":"https:\/\/lynxee.consulting\/","name":"Lynxee consulting","description":"Innovative support for regulatory issues","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/lynxee.consulting\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/lynxee.consulting\/#\/schema\/person\/8bd656ad92ca721913ddf5433730d240","name":"Adrien Margerit","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/lynxee.consulting\/#\/schema\/person\/image\/","url":"https:\/\/lynxee.consulting\/wp-content\/uploads\/2023\/10\/AMA_WP-96x96.jpg","contentUrl":"https:\/\/lynxee.consulting\/wp-content\/uploads\/2023\/10\/AMA_WP-96x96.jpg","caption":"Adrien Margerit"},"url":"https:\/\/lynxee.consulting\/en\/author\/adrien-margerit\/"}]}},"_links":{"self":[{"href":"https:\/\/lynxee.consulting\/en\/wp-json\/wp\/v2\/posts\/3268","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lynxee.consulting\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lynxee.consulting\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lynxee.consulting\/en\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/lynxee.consulting\/en\/wp-json\/wp\/v2\/comments?post=3268"}],"version-history":[{"count":3,"href":"https:\/\/lynxee.consulting\/en\/wp-json\/wp\/v2\/posts\/3268\/revisions"}],"predecessor-version":[{"id":6180,"href":"https:\/\/lynxee.consulting\/en\/wp-json\/wp\/v2\/posts\/3268\/revisions\/6180"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/lynxee.consulting\/en\/wp-json\/wp\/v2\/media\/3246"}],"wp:attachment":[{"href":"https:\/\/lynxee.consulting\/en\/wp-json\/wp\/v2\/media?parent=3268"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lynxee.consulting\/en\/wp-json\/wp\/v2\/categories?post=3268"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lynxee.consulting\/en\/wp-json\/wp\/v2\/tags?post=3268"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}